Docetaxel Based Chemotherapy Plus or Minus Induction Chemotherapy to Decrease Events in Head and Neck Cancer (DeCIDE)

Clinical trial NCT00117572 · COMPLETED

Trial details

NCT number: NCT00117572
Sponsor: University of Chicago
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Cancer of the Pharynx Cancer of the Larynx Cancer of the Nasal Cavity Paranasal Sinus Neoplasms Cancer of the Oral Cavity

Start date: 2004-11-01
Primary completion: 2016-12-01
Enrollment: 285

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.